Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Jul 30;17(11):1594–1601. doi: 10.1016/j.bbmt.2011.07.021

Figure 5. Non-relapse mortality from time of initiation of acute GVHD treatment.

Figure 5

“False-positive” line represents patients with an albumin decrease of ≥0.5 g/dL, but who did not progress to grade 3/4 acute GVHD. Non-relapse mortality is increased only in patients with an albumin decrease and severe acute GVHD, suggesting that the prognostic value of albumin decrease is linked entirely to its ability to predict severe acute GVHD.